DNAY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 saus. 2023 @ 07:00):

Stats
Dzisiejszy wolumen	19 945
Średni wolumen	79 397
Kapitalizacja rynkowa	38.32M
EPS	$-0.370 ( Q3 \| 2023-11-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.130 (10.00%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-08-31	Kullback William J	Buy	300 000	Stock Option (right to buy)
2023-08-28	Kullback William J	Buy	0
2023-10-18	Herrema Gregory J.	Buy	229 787	Stock Option (right to buy)
2023-10-18	Herrema Gregory J.	Buy	153 191	Common Stock
2023-10-18	Herrema Gregory J.	Buy	0

INSIDER POWER
96.64
Last 81 transactions
Buy: 30 855 803 \| Sell: 22 356 163

Wolumen Korelacja

Długi: 0.34 (neutral)

Krótki: -0.56 (weak negative)

Signal:(51.007) Neutral

Codex DNA, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Codex DNA, Inc. Korelacja - Waluta/Towar

0.60
( weak )

-0.60
( weak negative )

0.00
( neutral )

0.28
( neutral )

0.60
( weak )

-0.50
( weak negative )

Codex DNA, Inc. Finanse

Annual	2022
Przychody:	$27.44M
Zysk brutto:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2022
Przychody:	$27.44M
Zysk brutto:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2021
Przychody:	$11.04M
Zysk brutto:	$4.30M (38.93 %)
EPS:	$-1.828

FY	2020
Przychody:	$6.58M
Zysk brutto:	$3.63M (55.12 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Codex DNA, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Codex DNA, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.